Effects of small intravenous doses of epinephrine on serum insulin, glucose tolerance and serum free fatty acids.
D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000378:metabolism; D001681:Biological Assay; D001786:Blood Glucose / Q000378:metabolism*; D002110:Caffeine / Q000494:pharmacology; D004837:Epinephrine / Q000008:administration & dosage* / Q000652:urine; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D005947:Glucose / Q000008:administration & dosage; D005951:Glucose Tolerance Test; D006760:Hospitalization; D006801:Humans; D006868:Hydrolysis; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood*; D007743:Labor, Obstetric; D008238:Lysergic Acid Diethylamide / Q000008:administration & dosage; D008297:Male; D005082:Physical Exertion; D011247:Pregnancy; D013177:Sports; D013312:Stress, Physiological / Q000378:metabolism; D013315:Stress, Psychological; D013997:Time Factors
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D002110:Caffeine; D008238:Lysergic Acid Diethylamide; D005947:Glucose; D004837:Epinephrine